Obesity Paradox: Origin and best way to assess severity in patients with systolic HF

Obesity

Volumn 23, Issue 10, 2015, Pages 2002-2008

  Pozzo, Joffrey ^a,b   Fournier, Pauline ^a   Lairez, Olivier ^a,b,c   Vervueren, Paul Louis ^a,b   Delmas, Clement ^a,b   Elbaz, Meyer ^a,b   Carrie, Didier ^a,b   Galinier, Michel ^a,b,c   Roncalli, Jerome ^a,b,c  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

6 MINUTE WALKING TEST; ADULT; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; DYSPNEA; FEMALE; FOLLOW UP; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; HYPERTENSION; ISCHEMIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; OBESITY; OXYGEN CONSUMPTION; PROGNOSIS; PROTEIN BLOOD LEVEL; SEX RATIO; SYSTOLIC DYSFUNCTION; SYSTOLIC HEART FAILURE; UNIVARIATE ANALYSIS; WALKING; AGED; BLOOD; BODY FAT DISTRIBUTION; COMPARATIVE STUDY; COMPLICATION; HEART FAILURE; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

AGED; BIOMARKERS; BODY FAT DISTRIBUTION; BODY MASS INDEX; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OBESITY; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84942580991     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21216     Document Type: Article

References (31)

1. Curtis JP, Selter JG, Wang Y, et al., The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005; 165: 55-61.
2. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M., An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007; 153: 74-81.
3. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA., Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008; 156: 13-22.
4. Thomas JT, Kelly RF, Thomas SJ, et al., Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med 2002; 112: 437-445.
5. Fonarow GC, Stough WG, Abraham WT, et al., Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 2007; 50: 768-777.
6. O'Connor CM, Gattis WA, Shaw L, Cuffe MS, Califf RM., Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol 2000; 86: 863-867.
7. Hogg K, Swedberg K, McMurray J., Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004; 43: 317-327.
8. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM., Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
9. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH., The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001; 38: 789-795.
10. Nowbar S, Burkart KM, Gonzales R, et al., Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 2004; 116: 1-7.
11. Lazarus R, Sparrow D, Weiss ST., Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest 1997; 111: 891-898.
12. Rubinstein I, Zamel N, DuBarry L, Hoffstein V., Airflow limitation in morbidly obese, nonsmoking men. Ann Intern Med 1990; 112: 828-832.
13. McCord J, Mundy BJ, Hudson MP, et al., Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med 2004; 164: 2247-2252.
14. Sugisawa T, Kishimoto I, Kokubo Y, Makino H, Miyamoto Y, Yoshimasa Y., Association of plasma B-type natriuretic peptide levels with obesity in a general urban Japanese population: the Suita Study. Endocr J 2010; 57: 727-733.
15. Mehra MR, Uber PA, Park MH, et al., Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004; 43: 1590-1595.
16. Sarzani R, Dessi-Fulgheri P, Paci VM, Espinosa E, Rappelli A., Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 1996; 19: 581-585.
17. Sengenes C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J., Natriuretic peptides: a new lipolytic pathway in human adipocytes. Faseb J 2000; 14: 1345-1351.
18. Demers C, McKelvie RS, Negassa A, Yusuf S., Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. Am Heart J 2001; 142: 698-703.
19. Chlif M, Keochkerian D, Choquet D, Vaidie A, Ahmaidi S., Effects of obesity on breathing pattern, ventilatory neural drive and mechanics. Respir Physiol Neurobiol 2009; 168: 198-202.
20. Jensen D, Ofir D, O'Donnell DE., Effects of pregnancy, obesity and aging on the intensity of perceived breathlessness during exercise in healthy humans. Respir Physiol Neurobiol 2009; 167: 87-100.
21. Chinn DJ, Cotes JE, Reed JW., Longitudinal effects of change in body mass on measurements of ventilatory capacity. Thorax 1996; 51: 699-704.
22. Karason K, Lindroos AK, Stenlof K, Sjostrom L. Relief of cardiorespiratory symptoms and increased physical activity after surgically induced weight loss: results from the Swedish Obese Subjects study. Arch Intern Med 2000; 160: 1797-1802.
23. Franciosa JA, Wilen M, Ziesche S, Cohn JN., Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51: 831-836.
24. Arena R, Myers J, Abella J, et al., Influence of etiology of heart failure on the obesity paradox. Am J Cardiol 2009; 104: 1116-1121.
25. Chatterjee S, Chatterjee P, Bandyopadhyay A., Cardiorespiratory fitness of obese boys. Indian J Physiol Pharmacol 2005; 49: 353-357.
26. Goran M, Fields DA, Hunter GR, Herd SL, Weinsier RL., Total body fat does not influence maximal aerobic capacity. Int J Obes Relat Metab Disord 2000; 24: 841-848.
27. Zanconato S, Baraldi E, Santuz P, et al., Gas exchange during exercise in obese children. Eur J Pediatr 1989; 148: 614-617.
28. Aucouturier J, Rance M, Meyer M, et al., Determination of the maximal fat oxidation point in obese children and adolescents: validity of methods to assess maximal aerobic power. Eur J Appl Physiol 2009; 105: 325-331.
29. Cooper DM, Weiler-Ravell D, Whipp BJ, Wasserman K., Growth-related changes in oxygen uptake and heart rate during progressive exercise in children. Pediatr Res 1984; 18: 845-851.
30. Habedank D, Reindl I, Vietzke G, et al., Ventilatory efficiency and exercise tolerance in 101 healthy volunteers. Eur J Appl Physiol Occup Physiol 1998; 77: 421-426.
31. Davos CH, Doehner W, Rauchhaus M, et al., Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003; 9: 29-35.